A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548
Weller, M., Vlahovic, G., Khasraw, M., Brandes, A.A., Zwirtes, R., Tatsuoka, K., Carpentier, A.F., Reardon, D.A., Bent, M. van denVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw367.34
Date:
October, 2016
File:
PDF, 42 KB
english, 2016